Neonatal mortality risk for vulnerable newborn types in 15 countries using 125.5 million nationwide birth outcome records, 2000–2020
BJOG: An International Journal of Obstetrics & Gynaecology · 2025-11 · 132 (S8)
DOI: 10.1111/1471-0528.17506 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, online erschienen am 08.05.2023. Verfasst von Lorena Suárez-Idueta und 36 weiteren Autor:innen. Beteiligte Einrichtung: Mexican Society of Public Health, Mexico City, Mexico. Hauptthemen laut MEDLINE: Infant Mortality. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Children's Investment Fund Foundation.
Abstract (Originalsprache)
Objective
To compare neonatal mortality associated with six novel vulnerable newborn types in 125.5 million live births across 15 countries, 2000–2020.
Design
Population‐based, multi‐country study.
Setting
National data systems in 15 middle‐ and high‐income countries.
Methods
We used individual‐level data sets identified for the Vulnerable Newborn Measurement Collaboration. We examined the contribution to neonatal mortality of six newborn types combining gestational age (preterm [PT] versus term [T]) and size‐for‐gestational age (small [SGA], 90th centile) according to INTERGROWTH‐21st newborn standards. Newborn babies with PT or SGA were defined as small and T + LGA was considered as large. We calculated risk ratios (RRs) and population attributable risks (PAR%) for the six newborn types. Main outcome measures Mortality of six newborn types.
Results
Of 125.5 million live births analysed, risk ratios were highest among PT + SGA (median 67.2, interquartile range [IQR] 45.6–73.9), PT + AGA (median 34.3, IQR 23.9–37.5) and PT + LGA (median 28.3, IQR 18.4–32.3). At the population level, PT + AGA was the greatest contributor to newborn mortality (median PAR% 53.7, IQR 44.5–54.9). Mortality risk was highest among newborns born before 28 weeks (median RR 279.5, IQR 234.2–388.5) compared with babies born between 37 and 42 completed weeks or with a birthweight less than 1000 g (median RR 282.8, IQR 194.7–342.8) compared with those between 2500 g and 4000 g as a reference group.
Conclusion
Preterm newborn types were the most vulnerable, and associated with the highest mortality, particularly with co‐existence of preterm and SGA. As PT + AGA is more prevalent, it is responsible for the greatest burden of neonatal deaths at population level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mexican Society of Public Health, Mexico City, Mexico.
- Maternal, Adolescent, Reproductive & Child Health (MARCH) Centre, London School of Hygiene & Tropical Medicine, London, UK.
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Centre of Research Excellence in Stillbirth, Mater Research Institute, The University of Queensland, Brisbane, Queensland, Australia.
- Centre for Data Integration and Knowledge for Health (CIDACS), Instituto Gonçalo Moniz, Fiocruz Bahia, Fundação Oswaldo Cruz, Salvador, Brazil.
- Department of Obstetrics & Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Lorena Suárez-Idueta, Hannah Blencowe, Yemisrach B Okwaraji, Judith Yargawa, Ellen Bradley, Adrienne Gordon, Vicki Flenady, Enny S Paixao, Mauricio L Barreto, Sarka Lisonkova, Petr Velebil, Erzsebet Horváth-Puhó, Henrik Toft Sørensen, Luule Sakkeus, Liili Abuladze, Khalid A Yunis, Ayah Al Bizri, Fawziya Alyafei, Tawa O Olukade, Neda Razaz, Jonas Söderling, Lucy K Smith, Elizabeth S Draper, Estelle Lowry, Neil Rowland, Isabel Pereyra, Gabriella Pravia, Eric O Ohuma, Joy E Lawn
Förderung
- Medical Research Council
- Children's Investment Fund Foundation
Zitieren
APA
Suárez-Idueta, L., Blencowe, H., Okwaraji, Y. B., Yargawa, J., Bradley, E., Gordon, A., Flenady, V., Paixao, E. S., Barreto, M. L., Lisonkova, S., Wen, Q., Velebil, P., Jírová, J., Horváth-Puhó, E., Sørensen, H. T., Sakkeus, L., Abuladze, L., Yunis, K. A., Al Bizri, A., …, & National Vulnerable Newborn Mortality Collaborative Group and Vulnerable Newborn Measurement Core Group (2025). Neonatal mortality risk for vulnerable newborn types in 15 countries using 125.5 million nationwide birth outcome records, 2000–2020. BJOG: An International Journal of Obstetrics & Gynaecology, 132(S8). https://doi.org/10.1111/1471-0528.17506
Vancouver
Suárez-Idueta L, Blencowe H, Okwaraji YB, Yargawa J, Bradley E, Gordon A, et al. Neonatal mortality risk for vulnerable newborn types in 15 countries using 125.5 million nationwide birth outcome records, 2000–2020. BJOG: An International Journal of Obstetrics & Gynaecology. 2025;132(S8). doi:10.1111/1471-0528.17506
BibTeX
@article{SurezIdueta2025,
author = {Suárez-Idueta, Lorena and Blencowe, Hannah and Okwaraji, Yemisrach B and Yargawa, Judith and Bradley, Ellen and Gordon, Adrienne and Flenady, Vicki and Paixao, Enny S and Barreto, Mauricio L and Lisonkova, Sarka and Wen, Qi and Velebil, Petr and Jírová, Jitka and Horváth-Puhó, Erzsebet and Sørensen, Henrik Toft and Sakkeus, Luule and Abuladze, Liili and Yunis, Khalid A and Al Bizri, Ayah and Barranco, Arturo and Broeders, Lisa and van Dijk, Aimée E and Alyafei, Fawziya and Olukade, Tawa O and Razaz, Neda and Söderling, Jonas and Smith, Lucy K and Draper, Elizabeth S and Lowry, Estelle and Rowland, Neil and Wood, Rachael and Monteath, Kirsten and Pereyra, Isabel and Pravia, Gabriella and Ohuma, Eric O and Lawn, Joy E and National Vulnerable Newborn Mortality Collaborative Group and Vulnerable Newborn Measurement Core Group, National Vulnerable Newborn Mortality Collaborative Group and Vulnerable Newborn Measurement Core Group},
title = {Neonatal mortality risk for vulnerable newborn types in 15 countries using 125.5 million nationwide birth outcome records, 2000–2020},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2025},
volume = {132},
number = {S8},
doi = {10.1111/1471-0528.17506}
}
EUVIMED